LAMISIL
As listed in the register: LAMISIL 250 mg, comprimé sécable
281,25 mg · comprimé sécable
- Prescription only
- Active substance
- Chlorhydrate De Terbinafine
- Made by
- NOVARTIS PHARMA
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | NOVARTIS PHARMA |
|---|---|
| Active substance | Chlorhydrate De Terbinafine |
| Strength | 281,25 mg |
| Form | comprimé sécable |
| Route | orale |
| Dispensing (as stated by the register) | liste II |
| Marketed | No — authorised but not currently marketed, according to the register |
| Authorisation procedure | Procédure nationale |
| Name in the register | LAMISIL 250 mg, comprimé sécable |
| Packs | plaquette(s) PVC-Aluminium de 14 comprimé(s) · plaquette(s) PVC-Aluminium de 28 comprimé(s) |
| CIS | 66387487 |
| CIP13 | 3400933495657 |
| CIP13 | 3400933495718 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Other strengths and forms
3 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.